Nextel Medical

MAJI

Biotechnology · Healthcare

Price

$0.01

-0.00 (-12.50%)

Market Cap

$308,340

Winston Score

Winston is worried

Weak fundamentals across most pillars.

Based on the IPO prospectus (annual filing). This score will refine automatically once the company reports its first quarters.

Data as of Aug 23, 2026 · filings through Jun 30, 2026

How the score breaks down

Quality

Weak

Growth

Data not available

Cash Flow

Exceptional

Stability

Good

Valuation

Data not available

Track this stock — start free trial

Share count rising — dilution

+207.9% over 4y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 13.3M (2021) → 41.0M (2025)

Winston Score History

The full picture

Marijuana Inc. is a small company in the cannabis industry that focuses on hemp and marijuana-related products and services. It has operated in areas such as hemp cultivation, cannabis consulting, and related retail or distribution, primarily serving customers in legal cannabis markets within the United States. The company is a minor player in a fragmented specialty drug and cannabis sector.

The company generates revenue through product sales and services tied to the cannabis supply chain, but its financials show deeply negative margins, meaning it spends far more than it earns. It operates at a very small scale, with a market cap that rounds to essentially zero, and it has no clear competitive moat against larger, better-funded cannabis companies. The main risk facing Marijuana Inc. is straightforward: it is burning through money at an extreme rate, and without a significant improvement in revenue or a path to profitability, the business faces serious questions about its long-term survival.

Growth Profile

For growth stock investors

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

-100.0% YoY

YoY Growth Rate

Revenue declining

EPS Growth

-518.2% YoY

YoY Growth Rate

Earnings declining

R&D Spend

$252,946/ year

>1,000% of revenue

2810.5x the sector average (18%)

Research and development spending

Insider Activity

65.5%ownership

→ Flat

Insider ownership roughly steady over the past year

Cash Runway

5+ years

Quarterly Free Cash Flow

→ Burn rate stable

$14M cash & investments at current burn rate

Revenue declining

Nextel Medical's revenue is actually shrinking. In a growth stock, that removes the core investment thesis. The low Winston Score here may be warranted — unless there's a turnaround story.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale

Gross Margin

-34614.0%

Thin — -34614.0% gross margin

Profit after running costs

Operating Margin

-101746.8%

Losing money on operations — -101746.8%

Return on the money invested

ROCE

-3.7%

Weak — -3.7% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth

Sales YoY

N/A

Data not available

Profit growth

EPS YoY

N/A

—

Data not available

How steady the profit is

EPS Consistency

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash

Cash Conversion

103%

Turns 103% of profit into real cash

Spare cash per sale

FCF Margin

2788668.8%

Converts sales into free cash efficiently (2788668.8%)

Free cash flow margin above 20%. Out of every $100 in sales, more than $20 is real cash they keep.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns

Debt / Equity

0.02

Conservative — low debt load (0.02)

Covers its interest

Interest Cover

N/A

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit

P/E Ratio (TTM)

N/M

Negative earnings — P/E not meaningful

Cheaper or dearer next year

P/E vs Forward

N/A

not available

Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.

🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.

Start free trial